The company has seen six positive revisions in the past one month, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for this industry stock. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Array BioPharma currently carries a Zacks Rank #2 (Buy) while its Earnings ESP is negative.
Other well-placed stocks in the same industry include Affymetrix Inc. (AFFX), ANI Pharmaceuticals, Inc. (ANIP) and Biogen Idec Inc. (BIIB). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment